Is Nufarm stock a buy right now?
As of early May 2025, Nufarm Limited (ASX: NUF) is trading at approximately AU$3.86 per share, with recent average daily turnover just above 1 million shares— reflecting ongoing market interest despite a volatile year. The past 12 months have seen the stock decline over 25%; however, recent developments such as a 25% reduction in net debt, robust new product introductions, and steady growth in the high-potential omega-3 and seed technology segments are reshaping expectations. The February 2025 strategic partnership with KingAgroot on a new herbicide, together with improved performance in the Carinata oilseed platform, suggests management’s focus on innovation and revenue diversification is gaining traction. Although some caution remains following the FY2024 statutory net loss, market sentiment has grown more constructive, supported by favourable valuation metrics and a reasonable dividend yield of 2.33%. The agricultural chemicals sector in Australia continues to benefit from global food demand and ongoing innovation, offering resilience through cyclical challenges. According to the consensus of more than 29 national and international banks, the target price for Nufarm sits at AU$5.02. Investors evaluating medium- to longer-term opportunities may find Nufarm to be at an interesting juncture, particularly as the company builds on recent progress and prepares for its next financial update.
- Significant 25% net debt reduction, strengthening the balance sheet.
- Strong performance and expansion in omega-3 and seed technology markets.
- Diverse global operations limit geographic risk and enhance revenue stability.
- Attractive valuation metrics: low price-to-sales and price-to-book ratios.
- Reasonable 2.33% dividend yield, appealing for income-focused investors.
- Recent statutory net loss highlights ongoing profitability challenges.
- Exposure to weather, commodity, and seasonal volatility in the agricultural sector.
- What is Nufarm?
- How much is Nufarm stock?
- Our full analysis on Nufarm </b>stock
- How to buy Nufarm stock in Australia?
- Our 7 tips for buying Nufarm stock
- The latest news about Nufarm
- FAQ
Why trust HelloSafe?
At HelloSafe, our expert has been monitoring Nufarm's performance for over three years. Every month, hundreds of thousands of Australians rely on us to interpret market trends and highlight the best investment opportunities. Our analyses are provided for informational purposes only and do not constitute investment advice. In line with our ethical charter, we have never received, and will never receive, any payment or compensation from Nufarm.
What is Nufarm?
| Indicator | Value | Analysis |
|---|---|---|
| 🏳️ Nationality | Australia | Australian-based company with global operations and a long industry presence. |
| 💼 Market | ASX (Australian Securities Exchange) | Listed on Australia's primary exchange, providing transparency and liquidity. |
| 🏛️ ISIN code | AU000000NUF3 | Unique identifier confirming official listing and facilitating international trading. |
| 👤 CEO | Greg Hunt | CEO since 2015, leading strategic initiatives and overseeing global operations. |
| 🏢 Market cap | AU$1.48 billion | Reflects modest size; recent share price weakness signals investor caution. |
| 📈 Revenue | AU$1.8 billion (H1 2024) | Strong sales from diversified businesses despite sector volatility. |
| 💹 EBITDA | AU$313 million (FY2024, midpoint) | Healthy EBITDA demonstrates operational resilience under challenging market conditions. |
| 📊 P/E Ratio (Price/Earnings) | Not applicable (negative earnings) | A recent net loss means no meaningful P/E; returning to profit is the immediate challenge. |
How much is Nufarm stock?
The price of Nufarm stock is rising this week. As of now, shares are trading at AU$3.86, up 0.26% over the past 24 hours but down 0.52% for the week. Nufarm’s current market capitalisation stands at AU$1.48 billion, with an average daily trading volume of about 1,011,983 shares over the past three months.
| Indicator | Value |
|---|---|
| Share price | AU$3.86 |
| 24-hour change | +0.26% |
| Weekly change | -0.52% |
| Market capitalisation | AU$1.48 billion |
| Average daily trading volume (3 months) | 1,011,983 shares |
| P/E ratio | Not applicable (negative earnings) |
| Dividend yield | 2.33% |
| Beta | 0.45 |
With a beta of 0.45, the stock tends to be less volatile than the broader market—making it a steadier option for Australian investors seeking agricultural sector exposure.
Check out the best brokers in Australia!Compare brokersOur full analysis on Nufarm stock
After carefully reviewing Nufarm Limited’s (ASX: NUF) latest financial disclosures alongside its three-year share price evolution, we have consolidated a spectrum of analytical inputs—including financial ratios, technical indicators, peer benchmarking, and proprietary algorithmic models. This thorough evaluation highlights emerging opportunities and evolving sector dynamics. So, why might Nufarm stock once again become a strategic entry point into the agricultural technology sector in 2025?
Recent Performance and Market Context
Over the past year, Nufarm stock has experienced a notable correction, declining by 25.05%. However, the story beneath the headline numbers is more nuanced—and potentially more promising—than a simple glance at trailing returns might suggest. Year-to-date in 2025, Nufarm has demonstrated renewed momentum, advancing 9.04%. The broader macroeconomic backdrop also warrants attention: global demand for food security, heightened by climate unpredictability, is supporting structural growth in crop protection and agricultural innovation.
Recent operational highlights further strengthen Nufarm’s narrative. The company delivered a robust AU$313 million in underlying EBITDA for FY2024, at the midpoint of guidance, even as it navigated margin pressures and cyclical headwinds in its end-markets. Operational discipline was evident in a 25% year-on-year reduction in net debt, a critical signal of balance sheet fortification. In parallel, Nufarm’s Omega-3 segment achieved AU$50 million in revenue, testifying to the scalable potential of its differentiated biotech portfolio. A newly-announced partnership with KingAgroot—expanding Nufarm’s herbicide portfolio in February 2025—points to a proactive, innovation-driven approach in product development, a factor that may underpin revenue and margin recovery in the coming periods.
The company’s diversified revenue mix, spanning Australia, New Zealand, Asia, the Americas, and Europe, insulates it from region-specific volatility and amplifies exposure to emerging market growth. Market consensus continues to adopt a balanced stance, but present conditions—improving operational results and a measured, advantageous response to sector themes—lay the foundation for renewed optimism.
Technical Analysis
From a technical perspective, Nufarm’s share price currently stands at AU$3.86, trading within a consolidation range bounded by strong support at AU$3.82 and initial resistance at AU$3.89. Importantly, the stock price hovers above its 20-, 50-, and 100-day exponential moving averages (EMA)—signals often interpreted as incipient bullish momentum in the short and medium term. Notably:
- RSI (14): At 46.28, the stock is in a neutral zone, implying no significant overbought or oversold conditions.
- MACD (12,26,9): The reading of -0.01 gives a measured ‘sell’ indication; however, with the MACD near the signal line and the price consolidating, this setup often precedes a reversal, particularly when confirmed by price action at key support.
- Moving Averages: The convergence of the 20/50/100-day EMAs below the 200-day EMA reinforces the sense that the stock may be bottoming after a period of sustained weakness.
- Support/Resistance: Closest support levels between AU$3.82 and AU$3.75 offer a risk-defined entry, while resistance between AU$3.89 and AU$3.96 presents an early bullish target.
Overall, the technical landscape, although neither firmly bullish nor oversold, suggests the formation of a base at current levels—a common precursor to upside retracement, particularly in value-driven sector rotations. Short-term momentum and medium-term structure increasingly favour patient accumulation near support.
Fundamental Analysis
Nufarm’s fundamentals reflect resilience and transformation. Despite reporting a statutory net loss of AU$6 million in FY2024, the company maintained underlying EBITDA at AU$313 million (midpoint of guidance) and generated AU$1.8 billion in H1-2024 revenues. Management’s decisive focus on debt reduction—cutting net debt by 25% year-on-year to achieve 2.0x leverage on EBITDA—significantly enhances financial stability and lowers balance sheet risk.
The company’s valuation ratios are particularly compelling in today’s market:
- Price-to-Sales (P/S): 0.44, discounted relative to most peers in global agrochemicals, offering a rare opportunity to access sector leadership below book value.
- Price-to-Book (P/B): 0.67, signalling deep value—a metric that has historically preceded re-rating cycles, especially when paired with improving operational execution.
- Dividend Yield: A forward yield of 2.33% augments total return potential, providing an attractive cushion for income-focused portfolios.
Strategically, Nufarm is executing on several high-growth initiatives. Its Seed Technologies segment is expanding, with Omega-3 and Carinata (a sustainable biofuel crop) gaining commercial traction. The company’s innovation engine—backed by investments in intellectual property and partnerships—facilitates product launches in both conventional and emerging markets.
Nufarm’s broad geographic footprint, proven R&D capability, and deliberate capital allocation efforts combine to reinforce its competitive moat at a time when buyers are seeking exposure to stable, undervalued platforms positioned for cyclical recovery.
Volume and Liquidity
Liquidity and volume metrics further underscore Nufarm’s attractiveness as an investment vehicle. With an average daily volume exceeding 1 million shares and a market capitalization of AU$1.48 billion, Nufarm maintains a liquid float suitable for both institutional and retail participation. The robust trading volume observed throughout recent months, especially surrounding post-earnings periods and corporate news flow, is indicative of sustained market engagement—a positive for price discovery and dynamic valuations.
The relatively tight float, combined with consistent volume, suggests that price moves are less prone to extreme volatility while remaining responsive to catalysts. This supports the thesis that entry at current price levels can facilitate efficient execution and potential re-rating as confidence builds.
Catalysts and Positive Outlook
Several imminent and structural catalysts reinforce Nufarm’s positive investment thesis:
- New Product Pipeline: Ongoing launches from the company’s innovation funnel—particularly in seed treatments, bioenergy crops, and next-generation herbicides (e.g., KingAgroot partnership)—create avenues for margin expansion and market share gains.
- Progress in Omega-3 and Sustainable Agriculture: The Omega-3 platform’s AU$50 million revenue milestone reflects real commercial scalability; continued expansion could reposition Nufarm as a biotech leader in plant-based health solutions.
- Operational Resilience: Material reduction in net debt—combined with a tight cost discipline—fortifies Nufarm’s ability to weather agricultural cyclicality and pivot toward growth as commodity and input prices stabilise.
- Sectoral and Regulatory Trends: Growing regulatory focus on sustainable agriculture, ESG-driven capital flows, and government support for food security are creating tailwinds for technologically advanced, diversified platforms such as Nufarm.
- Strategic Partnerships and Geographic Expansion: Collaborations with global agrochemical innovators and ongoing growth in the Americas and Asia Pacific could unlock incremental revenues and diversify earning streams.
Looking forward, the half-year results announcement scheduled for May 21, 2025, represents a concrete, high-visibility event likely to provide new financial insights and operational milestones. This catalyst could act as a trigger for renewed investor attention and price momentum, especially if management confirms a return to sustained profitability or articulates further growth initiatives.
Investment Strategies
Nufarm’s current market dynamics offer flexible strategies for investors seeking participation in the agricultural innovation rebound.
- Short-Term Entry: For active traders, the consolidation near AU$3.82 support, coupled with improving short-term moving averages, may present a tactical entry ahead of the upcoming results release in May. The risk-reward ratio is attractive given well-defined stops below the recent 52-week low (AU$3.47) and upside potential toward the initial resistance band (AU$3.89–AU$3.96).
- Medium-Term Perspective: Investors looking to capitalise on operational recovery and sector tailwinds can position over the coming quarters. Positive newsflow on product launches, partnership benefits, and disciplined cost control can act as catalysts for a gradual re-rating and restoration of market confidence.
- Long-Term Value Play: For patient, long-term capital, Nufarm’s foundational strengths—deep value, attractive yield, global diversification, and the upside of agricultural innovation—support the case for sustained accumulation. History suggests that such platforms, when bought at trough multiples during cyclical lulls, tend to reward conviction as earnings normalise and innovation cycles mature.
Those entering now benefit from layering in at what appears to be a technical low, with the added leverage of being positioned ahead of meaningful catalysts and sector rotation. Each investment style can frame its entry parameters based on risk appetite and strategic view, but the argument for reconsidering exposure at current levels is compelling.
Is It the Right Time to Buy Nufarm?
In summary, Nufarm stands at an inflection point: structural balance sheet improvements, a pipeline of innovation, strategic partnerships, and deep value metrics converge to create a fertile environment for new investor interest. Technical indicators suggest basing action, market volumes remain robust, and upcoming catalysts offer clear potential for positive surprise. The combination of defensive dividend yield and outsized recovery prospects positions Nufarm as arguably one of the more underappreciated plays in the agricultural technology arena.
While past profitability challenges and sector volatility are not to be ignored, the fundamentals justify renewed attention, with the current entry zone appearing particularly favourable for investors anticipating a rebound. Nufarm may indeed be entering a new bullish phase—one that could reward both nimble traders and patient holders willing to capitalise on cyclical turnaround and sustained innovation in global agritechnology.
As the sector pivots toward sustainable and intelligent solutions, Nufarm’s unique positioning and proactive strategy make it a stock that seems to represent an excellent opportunity for those looking to participate in the next chapter of agricultural transformation.
How to buy Nufarm stock in Australia?
Buying Nufarm stock online is a simple and secure process when you use a regulated Australian broker. Whether you're a beginner or an experienced investor, you can invest in Nufarm shares directly (“spot buying”) or trade via Contracts for Difference (CFDs) for more flexible strategies. Spot buying means you own the actual shares, while CFDs allow you to speculate on the price movements with leverage. Each method has its advantages and different costs. To help you choose the right platform, a detailed broker comparison is available further down the page.
Cash buying
What is a cash purchase of Nufarm stock?
A cash (or “spot”) purchase involves buying real Nufarm shares on the Australian Securities Exchange (ASX) through a licensed broker. You become a direct shareholder, eligible for dividends and company voting rights. Typical fees for this method include a fixed commission per order, often around AU$5–AU$10, depending on the broker.
Concrete example
Suppose Nufarm shares are trading at AU$3.86 each. With a AU$1,000 investment and a typical AU$5 brokerage fee, you could buy approximately 257 shares (AU$995 / AU$3.86 ≈ 257 shares).
✔️ Gain scenario:
If the Nufarm share price increases by 10%, your shares are now worth AU$1,100.
Result: +AU$100 gross gain, or +10% on your investment.
Trading via CFD
What is CFD trading on Nufarm shares?
CFDs (Contracts for Difference) allow you to speculate on Nufarm’s share price movements without actually owning the shares. With CFDs, you can leverage your exposure — often up to 5× or more. However, you’ll pay a spread (the difference between buy and sell prices) and, if you hold overnight, daily financing fees.
Example with AU$1,000 and 5x leverage
You open a CFD on Nufarm with a AU$1,000 margin and 5x leverage, giving you AU$5,000 in market exposure.
✔️ Gain scenario:
If the share price rises by 8%, your position gains 8% × 5 = 40%.
Result: +AU$400 gain on your AU$1,000 stake (excluding fees).
Final advice
Before buying, it’s essential to compare brokers’ fees, available trading tools, and the level of customer support to ensure you get the best deal for your needs. Your choice between spot buying and CFD trading should reflect your investment objectives and risk appetite. See the broker comparison table further down the page to help you choose the right platform for your Nufarm investment.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions, including ASIC (Australia). They are also regulated by the Central Bank of Ireland, the AMF in France, and the FSA (Japan). Active since 2006, it offers solid guarantees, including the separation of client funds and strict compliance with international standards. With over 300,000 active users, it inspires confidence in both novice and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. Tutorials, demo accounts and free training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don't need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when you pay.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you're looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is a great choice.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions, including ASIC (Australia). They are also regulated by the Central Bank of Ireland, the AMF in France, and the FSA (Japan). Active since 2006, it offers solid guarantees, including the separation of client funds and strict compliance with international standards. With over 300,000 active users, it inspires confidence in both novice and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. Tutorials, demo accounts and free training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don't need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when you pay.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you're looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is a great choice.
Is IG reliable?
IG is a trustworthy trading platform, regulated by top authorities such as the CFTC and NFA in the United States, ensuring your funds are secure. It has strong measures in place to protect users and guarantees complete transparency. Thousands of clients worldwide vouch for its reliability and security.
Why choose IG?
IG stands out with its user-friendly interface, making it perfect for beginners. It offers unique tools like IG Academy and ProRealTime for learning and market analysis. The platform provides access to a wide range of assets, including stocks, ETFs, and cryptocurrencies, along with a strong community for trading discussions.
What are the fees at IG?
IG offers competitive spreads with no commissions on buying stocks or ETFs. Withdrawal fees are transparent, and inactivity fees apply after one year without activity. The platform maintains a clear pricing structure, allowing users to easily understand all costs related to their transactions.
Who is IG for?
IG is perfect for beginner and intermediate traders due to its simple interface and educational resources. It also caters to experienced investors with advanced trading tools. Users have access to a wide variety of assets like stocks, cryptocurrencies, and ETFs, making it suitable for diversifying portfolios.
Is IG reliable?
IG is a trustworthy trading platform, regulated by top authorities such as the CFTC and NFA in the United States, ensuring your funds are secure. It has strong measures in place to protect users and guarantees complete transparency. Thousands of clients worldwide vouch for its reliability and security.
Why choose IG?
IG stands out with its user-friendly interface, making it perfect for beginners. It offers unique tools like IG Academy and ProRealTime for learning and market analysis. The platform provides access to a wide range of assets, including stocks, ETFs, and cryptocurrencies, along with a strong community for trading discussions.
What are the fees at IG?
IG offers competitive spreads with no commissions on buying stocks or ETFs. Withdrawal fees are transparent, and inactivity fees apply after one year without activity. The platform maintains a clear pricing structure, allowing users to easily understand all costs related to their transactions.
Who is IG for?
IG is perfect for beginner and intermediate traders due to its simple interface and educational resources. It also caters to experienced investors with advanced trading tools. Users have access to a wide variety of assets like stocks, cryptocurrencies, and ETFs, making it suitable for diversifying portfolios.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including ASIC (Australia). It is also regulated by the FCA (UK) and CySEC (Europe). With over 30 million users worldwide, eToro is widely recognised for its security and transparency. Based on our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don’t need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while investing.
You have access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community for exchanging ideas: eToro makes investing simple, interactive and educational. It's a bit like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of stocks or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposits are free, and withdrawals are set at $5 USD. In the event that you remain inactive for 12 months or more, a $10 USD monthly fee applies.
Finally, the fees charged are also clearly stated on its website (we can't say the same about all competitors).
Who is eToro for?
eToro is mainly for beginners and intermediates, thanks to its simplicity and educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including ASIC (Australia). It is also regulated by the FCA (UK) and CySEC (Europe). With over 30 million users worldwide, eToro is widely recognised for its security and transparency. Based on our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don’t need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while investing.
You have access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community for exchanging ideas: eToro makes investing simple, interactive and educational. It's a bit like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of stocks or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposits are free, and withdrawals are set at $5 USD. In the event that you remain inactive for 12 months or more, a $10 USD monthly fee applies.
Finally, the fees charged are also clearly stated on its website (we can't say the same about all competitors).
Who is eToro for?
eToro is mainly for beginners and intermediates, thanks to its simplicity and educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Our 7 tips for buying Nufarm stock
| Step | Specific tip for Nufarm |
|---|---|
| Analyse the market | Review the recent performance of Nufarm and its sector, focusing on agricultural market trends and the company's 12-month share price decline to spot entry opportunities in Australia. |
| Choose the right trading platform | Pick an Australian broker that offers ASX access, competitive fees, and research tools to make the NUF.AX buying process smooth and cost-effective. |
| Define your investment budget | Set an investment amount within your financial comfort zone, bearing in mind Nufarm’s dividend yield, recent volatility, and potential for recovery. |
| Choose a strategy (short or long term) | Consider a longer-term approach to benefit from Nufarm’s innovation in seed technologies and omega-3, allowing time for business fundamentals to drive value. |
| Monitor news and financial results | Stay updated on Nufarm’s half-year and full-year results, especially announcements about their debt reduction, product launches, and upcoming earnings in May 2025. |
| Use risk management tools | Protect your investment by using stop-loss orders and position sizing, as Nufarm’s share price can be influenced by sector swings and seasonal factors. |
| Sell at the right time | Aim to take profits when the stock approaches resistance levels, or after positive financial updates, while watching for signals of sustained uptrends or market reversals. |
The latest news about Nufarm
Nufarm’s share price has moved up 0.26% this week, outperforming both the sector and the ASX 200. Over the last five trading days, Nufarm stock stabilized following April’s broader market softness, providing a subtle sign of resilience ahead of key May earnings. This modest gain stands in contrast to the negative performance of the broader Basic Materials sector in Australia and indicates improving short-term investor sentiment, likely driven by confidence in recent balance sheet improvements and upcoming catalysts.
Successful reduction of net debt by 25% over the past year strengthens Nufarm’s financial stability. The company’s latest disclosures highlight a substantial net debt reduction, with net leverage now sitting at 2.0x underlying EBITDA. This disciplined approach to financial management is particularly notable against a backdrop of ongoing global supply chain volatility and supports the investment case for sustained dividend payments and capacity for targeted growth investment, both of which are positive signals for Australian shareholders.
Recent expansion in the Omega-3 business has delivered AU$50 million revenue and improved plant oil profile. Nufarm’s innovative push into omega-3 oil production using proprietary canola seed technology continues to bear fruit, with plantings increasing throughout 2024 and resulting in strengthened product profiles. This diversification into higher-margin, health-oriented agricultural products positions the company well for growth, resonates with the Australian government’s focus on value-added agricultural exports, and demonstrates tangible progress in Nufarm’s strategic pivot beyond traditional crop protection.
Technical trading signals point to near-term stability after a prolonged share price decline. With the stock currently trading above its 20-day, 50-day, and 100-day exponential moving averages, short-term technical strength is evident despite year-long underperformance. The RSI remains neutral, and MACD negative, but strong support at AU$3.82 suggests downside is presently limited, while closing in on first resistance at AU$3.89 presents upside potential should positive momentum continue. This technical backdrop provides opportunity for medium-term Australian investors seeking a value recovery story.
Upcoming H1 FY2025 results announcement is expected to deliver further clarity on growth momentum and capital management. The market is now closely watching Nufarm’s half-year results, scheduled for May 21, 2025, with consensus focusing on the company’s ability to convert strategic investments—such as its KingAgroot herbicide partnership and expansion in Carinata and omega-3—into improved profitability. Management’s continued progress in these priority areas, coupled with the visibly healthier balance sheet and continued dividend payments (next ex-dividend date May 29), is anticipated to support further positive sentiment in the Australian market if guidance is affirmed or upgraded.
FAQ
What is the latest dividend for Nufarm stock?
Nufarm currently pays a dividend. The latest interim dividend was AU$0.04 per share, paid unfranked, with an ex-dividend date of May 29, 2024. The forward annual dividend is AU$0.09, yielding around 2.33%. Notably, Nufarm’s dividend payouts have resumed after a period of volatility, indicating confidence despite recent earnings challenges.
What is the forecast for Nufarm stock in 2025, 2026, and 2027?
Based on the current share price of AU$3.86, the projected price for Nufarm stock is AU$5.02 at the end of 2025, AU$5.79 at the end of 2026, and AU$7.72 at the end of 2027. These optimistic forecasts reflect growing momentum in Nufarm’s innovative seed technologies and improving fundamentals, plus ongoing benefits from reduced debt and global diversification.
Should I sell my Nufarm shares?
Holding onto Nufarm shares could be appropriate for medium- to long-term investors. The company is showing strategic resilience by expanding in high-growth areas like omega-3 and carinata, while significantly reducing its debt. With its global reach and attractive valuation, Nufarm remains well-positioned to benefit from sector trends, even amid recent volatility and challenges.
How are dividends and capital gains from Nufarm shares taxed in Australia?
For Australian investors, dividends from Nufarm are taxed at your marginal income tax rate. Since the latest dividends are unfranked, no franking credit offset applies. Capital gains from selling Nufarm shares are taxed under Australian CGT rules, with a 50% discount available if held for more than 12 months. There is no withholding tax for resident individuals on domestic share dividends.
What is the latest dividend for Nufarm stock?
Nufarm currently pays a dividend. The latest interim dividend was AU$0.04 per share, paid unfranked, with an ex-dividend date of May 29, 2024. The forward annual dividend is AU$0.09, yielding around 2.33%. Notably, Nufarm’s dividend payouts have resumed after a period of volatility, indicating confidence despite recent earnings challenges.
What is the forecast for Nufarm stock in 2025, 2026, and 2027?
Based on the current share price of AU$3.86, the projected price for Nufarm stock is AU$5.02 at the end of 2025, AU$5.79 at the end of 2026, and AU$7.72 at the end of 2027. These optimistic forecasts reflect growing momentum in Nufarm’s innovative seed technologies and improving fundamentals, plus ongoing benefits from reduced debt and global diversification.
Should I sell my Nufarm shares?
Holding onto Nufarm shares could be appropriate for medium- to long-term investors. The company is showing strategic resilience by expanding in high-growth areas like omega-3 and carinata, while significantly reducing its debt. With its global reach and attractive valuation, Nufarm remains well-positioned to benefit from sector trends, even amid recent volatility and challenges.
How are dividends and capital gains from Nufarm shares taxed in Australia?
For Australian investors, dividends from Nufarm are taxed at your marginal income tax rate. Since the latest dividends are unfranked, no franking credit offset applies. Capital gains from selling Nufarm shares are taxed under Australian CGT rules, with a 50% discount available if held for more than 12 months. There is no withholding tax for resident individuals on domestic share dividends.
